Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Intestinal Microbiota for Decolonization of MDROs
NCT07496502Phase 2Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in organism colonization and Clostridioides difficile infection (CDI) (2 arms), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoint: Proportion of patients with intestinal decolonization of baseline MDROs or toxigenic C. difficile at 14 days. Started Mar 2022; status: completed.
02
Conditions
organism colonizationClostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT07496502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496502.